Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.

To further understand the temporal mode and mechanisms of coronary restenosis, 229 patients were studied by prospective angiographic follow-up on day 1 and at 1, 3 and 6 months and 1 year after successful percutaneous transluminal coronary angioplasty. Quantitative measurement of coronary stenosis was achieved by cinevideodensitometric analysis. Actuarial restenosis rate was 12.7% at 1 month, 43.0% at 3 months, 49.4% at 6 months and 52.5% at 1 year. In 219 patients followed up for greater than or equal to 3 months, mean stenosis diameter was 1.91 +/- 0.53 mm immediately after coronary angioplasty, 1.72 +/- 0.52 mm on day 1, 1.86 +/- 0.58 mm at 1 month and 1.43 +/- 0.67 mm at 3 months. In 149 patients followed up for greater than or equal to 6 months, mean stenosis diameter was 1.66 +/- 0.58 mm at 3 months and 1.66 +/- 0.62 mm at 6 months. In 73 patients followed up for 1 year, mean stenosis diameter was 1.65 +/- 0.56 mm at 6 months and 1.66 +/- 0.57 mm at 1 year. Thus, stenosis diameter decreased markedly between 1 month and 3 months after coronary angioplasty and reached a plateau thereafter. In conclusion, restenosis is most prevalent between 1 and 3 months and rarely occurs beyond 3 months after coronary angioplasty.

This article has been cited by other articles:

				D. R. Holmes Jr and D. O. Williams Catheter-Based Treatment of Coronary Artery Disease: Past, Present, and Future Circ Cardiovasc Intervent, August 1, 2008; 1(1): 60 - 73. [Abstract] [Full Text] [PDF]

				K. Tanaka, M. Sata, T. Natori, J.-r. Kim-Kaneyama, K. Nose, M. Shibanuma, Y. Hirata, and R. Nagai Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice FASEB J, February 1, 2008; 22(2): 428 - 436. [Abstract] [Full Text] [PDF]

				J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]

				V. A. Korshunov, S. M. Schwartz, and B. C. Berk Vascular Remodeling: Hemodynamic and Biochemical Mechanisms Underlying Glagov's Phenomenon Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1722 - 1728. [Abstract] [Full Text] [PDF]

				T. Svilaas, I. C C van der Horst, and F. Zijlstra A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: angiographic measures in relation to clinical outcome Heart, July 1, 2007; 93(7): 792 - 800. [Abstract] [Full Text] [PDF]

				H. Konishi, K. Sydow, and J. P. Cooke Dimethylarginine Dimethylaminohydrolase Promotes Endothelial Repair After Vascular Injury J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1099 - 1105. [Abstract] [Full Text] [PDF]

				C.-H. Lee, H.-C. Tan, and Y.-T. Lim Update on Drug-Eluting Stents for Prevention of Restenosis Asian Cardiovasc Thorac Ann, February 1, 2006; 14(1): 75 - 82. [Abstract] [Full Text] [PDF]

				Y. Kitta, T. Nakamura, Y. Kodama, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, Y. Ichigi, et al. Endothelial Vasomotor Dysfunction in the Brachial Artery Is Associated With Late In-Stent Coronary Restenosis J. Am. Coll. Cardiol., August 16, 2005; 46(4): 648 - 655. [Abstract] [Full Text] [PDF]

				L. Mauri, E. J. Orav, and R. E. Kuntz Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison Circulation, June 28, 2005; 111(25): 3435 - 3442. [Abstract] [Full Text] [PDF]

				W. Hueb, P. R. Soares, B. J. Gersh, L. A. M. Cesar, P. L. Luz, L. B. Puig, E. M. Martinez, S. A. Oliveira, and J. A. F. Ramires The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: One-year results J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1743 - 1751. [Abstract] [Full Text] [PDF]

				K. N. Giedd and S. R. Bergmann Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention J. Am. Coll. Cardiol., February 4, 2004; 43(3): 328 - 336. [Abstract] [Full Text] [PDF]

				M. Sata, K. Tanaka, N. Ishizaka, Y. Hirata, and R. Nagai Absence of p53 Leads to Accelerated Neointimal Hyperplasia After Vascular Injury Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1548 - 1552. [Abstract] [Full Text] [PDF]

				S. R. Bergmann and K. N. Giedd Silent ischemia: unsafe at any time J. Am. Coll. Cardiol., July 2, 2003; 42(1): 41 - 44. [Full Text] [PDF]

				B. J. Pearce and J. F. McKinsey Current Status of Intravascular Stents as Delivery Devices to Prevent Restenosis Vascular and Endovascular Surgery, July 1, 2003; 37(4): 231 - 237. [Abstract] [PDF]

				P. Rubartelli, E. Verna, L. Niccoli, C. Giachero, M. Zimarino, G. Bernardi, C. Vassanelli, L. Campolo, E. Martuscelli, and Gruppo Italiano di Studio sullo Stent nelle Occlus Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1488 - 1492. [Abstract] [Full Text] [PDF]

				P. Urban, P. Serruys, D. Baumgart, A. Colombo, S. Silber, E. Eeckhout, A. Gershlick, K. Wegscheider, L. Verhees, R. Bonan, et al. A multicentre European registry of intraluminal coronary beta brachytherapy Eur. Heart J., April 1, 2003; 24(7): 604 - 612. [Abstract] [Full Text] [PDF]

				R. Bonvini, I. Baumgartner, D. D. Do, M. Alerci, J.-M. Segatto, P. Tutta, K. Jager, M. Aschwanden, E. Schneider, B. Amann-Vesti, et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries J. Am. Coll. Cardiol., February 5, 2003; 41(3): 409 - 412. [Abstract] [Full Text] [PDF]

				J. T. Willerson Myocardial Revascularization with Cardiologic Interventional Devices Card. Surg. Adult, January 1, 2003; 2(2003): 561 - 580. [Full Text]

				Q. J. Zhang, M. Goddard, C. Shanahan, L. Shapiro, and M. Bennett Differential Gene Expression in Vascular Smooth Muscle Cells in Primary Atherosclerosis and In Stent Stenosis in Humans Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2030 - 2036. [Abstract] [Full Text] [PDF]

				D. R. Holmes Jr, M. Savage, J.-M. LaBlanche, L. Grip, P.W. Serruys, P. Fitzgerald, D. Fischman, S. Goldberg, J. A. Brinker, A.M. Zeiher, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial Circulation, September 3, 2002; 106(10): 1243 - 1250. [Abstract] [Full Text] [PDF]

				M. Sata, A. Takahashi, K. Tanaka, M. Washida, N. Ishizaka, J. Ako, M. Yoshizumi, Y. Ouchi, T. Taniguchi, Y. Hirata, et al. Mouse Genetic Evidence That Tranilast Reduces Smooth Muscle Cell Hyperplasia via a p21WAF1-Dependent Pathway Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1305 - 1309. [Abstract] [Full Text] [PDF]

				X. Wang and B. Paigen Comparative Genetics of Atherosclerosis and Restenosis: Exploration With Mouse Models Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 884 - 886. [Full Text] [PDF]

				R Mansfield, S Bown, and J McEwan Photodynamic therapy: shedding light on restenosis Heart, December 1, 2001; 86(6): 612 - 618. [Full Text] [PDF]

				M. Ii, M. Hoshiga, R. Fukui, N. Negoro, T. Nakakoji, F. Nishiguchi, E. Kohbayashi, T. Ishihara, and T. Hanafusa Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27Kip1 Cardiovasc Res, December 1, 2001; 52(3): 500 - 508. [Abstract] [Full Text] [PDF]

				W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF]

				S. O. Marx and A. R. Marks Bench to Bedside: The Development of Rapamycin and Its Application to Stent Restenosis Circulation, August 21, 2001; 104(8): 852 - 855. [Full Text] [PDF]

				P. Schoenhagen, K. M. Ziada, D. G. Vince, S. E. Nissen, and E. M. Tuzcu Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis J. Am. Coll. Cardiol., August 1, 2001; 38(2): 297 - 306. [Abstract] [Full Text] [PDF]

				K. Aragane, K. Fujinami, K. Kojima, and J. Kusunoki ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits J. Lipid Res., April 1, 2001; 42(4): 480 - 488. [Abstract] [Full Text]

				A Wahl, M Billinger, M Fleisch, B Meier, and C Seiler Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization Eur. Heart J., November 1, 2000; 21(21): 1776 - 1784. [Abstract] [PDF]

				N. Kipshidze, J. J. Ferguson III, M. H. Keelan Jr., H. Sahota, R. Komorowski, L. R. Shankar, P. S. Chawla, C. C. Haudenschild, V. Nikolaychik, and J. W. Moses Endoluminal reconstruction of the arterial wall with endothelial cell/glue matrix reduces restenosis in an atherosclerotic rabbit J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1396 - 1403. [Abstract] [Full Text] [PDF]

				S. Kageyama, H. Yamamoto, and R. Yoshimoto Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2303 - 2308. [Abstract] [Full Text] [PDF]

				H. Adachi, A. Koike, A. Niwa, A. Sato, T. Takamoto, F. Marumo, and M. Hiroe Percutaneous Transluminal Coronary Angioplasty Improves Oxygen Uptake Kinetics During the Onset of Exercise in Patients With Coronary Artery Disease Chest, August 1, 2000; 118(2): 329 - 335. [Abstract] [Full Text] [PDF]

				H. Tamai, K. Igaki, E. Kyo, K. Kosuga, A. Kawashima, S. Matsui, H. Komori, T. Tsuji, S. Motohara, and H. Uehata Initial and 6-Month Results of Biodegradable Poly-l-Lactic Acid Coronary Stents in Humans Circulation, July 25, 2000; 102(4): 399 - 404. [Abstract] [Full Text] [PDF]

				M. Gottsauner-Wolf, G. Zasmeta, S. Hornykewycz, M. Nikfardjam, E. Stepan, P. Wexberg, G. Zorn, D. Glogar, P. Probst, G. Maurer, et al. Plasma levels of C-reactive protein after coronary stent implantation Eur. Heart J., July 2, 2000; 21(14): 1152 - 1158. [Abstract] [PDF]

				R. E. Kuntz and D. S. Baim Prevention of Coronary Restenosis : The Evolving Evidence Base for Radiation Therapy Circulation, May 9, 2000; 101(18): 2130 - 2133. [Full Text] [PDF]

				I. Ogawa, T. Hayashi, T. Nakabayashi, N. Otani, K. Ishikawa, and K. Kanamasa Prevention of Coronary Arterial Renarrowing by Continuous 3-Day Infusion of Tissue Plasminogen Activator After Successful Percutaneous Transluminal Coronary Angioplasty: A Randomized, Double-Blind, Placebo-Controlled Study Angiology, May 1, 2000; 51(5): 367 - 375. [Abstract] [PDF]

				Y Hojo, U Ikeda, T Katsuki, O Mizuno, H Fujikawa, and K Shimada Inhibition of angiotensin converting enzyme cannot prevent increases in angiotensin II production in coronary circulation Heart, May 1, 2000; 83(5): 574 - 576. [Abstract] [Full Text]

				B. Jorgensen, S. Simonsen, K. Endresen, K. Forfang, K. Vatne, J. Hansen, J. Webb, C. Buller, G. Goulet, J. Erikssen, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) J. Am. Coll. Cardiol., March 1, 2000; 35(3): 592 - 599. [Abstract] [Full Text] [PDF]

				I P Kay, M Sabate, G Van Langenhove, M A Costa, A J Wardeh, A L Gijzel, N V Deshpande, S G Carlier, V L M A Coen, P C Levendag, et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation Heart, March 1, 2000; 83(3): 332 - 337. [Abstract] [Full Text]

				A. Rivard, N. Principe, and V. Andres Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells: A potential link between aging, smooth muscle cell proliferation and atherosclerosis Cardiovasc Res, March 1, 2000; 45(4): 1026 - 1034. [Abstract] [Full Text] [PDF]

				J. Kamenz, W. Seibold, M. Wohlfrom, S. Hanke, N. Heise, C. Lenz, and H. Hanke Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model Cardiovasc Res, February 1, 2000; 45(3): 766 - 776. [Abstract] [Full Text] [PDF]

				M. P Jenkins, G. A Buonaccorsi, R. Mansfield, C. C.R Bishop, S. G Bown, and J. R McEwan Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolaevulinic acid Cardiovasc Res, January 14, 2000; 45(2): 478 - 485. [Abstract] [Full Text] [PDF]

				J. Lindsay Jr., E. E. Pinnow, and A. D. Pichard Frequency of major adverse cardiac events within one month of coronary angioplasty: a useful measure of operator performance J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1916 - 1923. [Abstract] [Full Text] [PDF]

				A. Betriu, M. Masotti, A. Serra, J. Alonso, F. Fernandez-Aviles, F. Gimeno, T. Colman, J. Zueco, J. L. Delcan, E. Garcia, et al. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1498 - 1506. [Abstract] [Full Text] [PDF]

				B Jorgensen, S Simonsen, K Endresen, K Forfang, T Egeland, A.T Hostmark, and E Thaulow Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids Eur. Heart J., October 1, 1999; 20(19): 1407 - 1414. [Abstract] [PDF]

				K. Yokoya, H. Takatsu, T. Suzuki, H. Hosokawa, S. Ojio, T. Matsubara, T. Tanaka, S. Watanabe, N. Morita, K. Nishigaki, et al. Process of Progression of Coronary Artery Lesions From Mild or Moderate Stenosis to Moderate or Severe Stenosis : A Study Based on Four Serial Coronary Arteriograms per Year Circulation, August 31, 1999; 100(9): 903 - 909. [Abstract] [Full Text] [PDF]

				L.-Q. Sun, M. J. Cairns, W. L. Gerlach, C. Witherington, L. Wang, and A. King Suppression of Smooth Muscle Cell Proliferation by a c-myc RNA-cleaving Deoxyribozyme J. Biol. Chem., June 11, 1999; 274(24): 17236 - 17241. [Abstract] [Full Text] [PDF]

				J. M. Bosmans, C. J. Vrints, M. M. Kockx, H. Bult, K. M. C. Cromheeke, and A. G. Herman Continuous Perivascular L-Arginine Delivery Increases Total Vessel Area and Reduces Neointimal Thickening After Experimental Balloon Dilatation Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 767 - 776. [Abstract] [Full Text] [PDF]

				R. L. Wilensky, K. Mehdi, K. M. Sowinski, Sang Hong Baek, and K. L. March Increased Intramural Retention After Local Delivery of Molecules with Increased Binding Properties: Implications for Regional Delivery of Pharmacologic Agents Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(2): 103 - 112. [Abstract] [PDF]

				M. Labinaz, K. Pels, C. Hoffert, S. Aggarwal, and E. R O'Brien Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries Cardiovasc Res, January 1, 1999; 41(1): 255 - 266. [Abstract] [Full Text] [PDF]

				R. Erbel, M. Haude, H. W. Hopp, D. Franzen, H. J. Rupprecht, B. Heublein, K. Fischer, P. de Jaegere, P. Serruys, W. Rutsch, et al. Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty N. Engl. J. Med., December 3, 1998; 339(23): 1672 - 1678. [Abstract] [Full Text] [PDF]

				S. G. Ellis, A. M. Lincoff, D. Miller, J. E. Tcheng, N. S. Kleiman, D. Kereiakes, R. Califf, E. J. Topol, and for the EPIC and EPILOG Investigators Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1619 - 1623. [Abstract] [Full Text] [PDF]

				A. J. Lansky, G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, D. S. Baim, R. E. Kuntz, C. Simonton, R. M. Bersin, et al. Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the optimal atherectomy restenosis study J. Am. Coll. Cardiol., August 1, 1998; 32(2): 329 - 337. [Abstract] [Full Text] [PDF]

				B.J.G.L de Smet, J van der Zande, Y.J.M van der Helm, R.E Kuntz, C Borst, and M.J Post The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling Cardiovasc Res, July 1, 1998; 39(1): 224 - 232. [Abstract] [Full Text] [PDF]

K. Guo, V. Andres, and K. Walsh Nitric Oxide–Induced Downregulation of Cdk2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells Circulation, May 26, 1998; 97(20): 2066 - 2072